Breaking News

Alnylam Pharmaceuticals Inc DRC (A1LN34)

Symbol	Exchange	Currency
A1LN34	B3	BRL	Delayed
ALNY	NASDAQ	USD	Real-time
ALNY	BIVA	MXN	Delayed
ALNY	TradeGate	EUR	Delayed

Add to/Remove from a Portfolio Add to Watchlist

77.28 +1.76 +2.33%

02:28:59 - Closed. Currency in BRL

Type: Equity

Market: Brazil

ISIN: BRA1LNBDR003

Volume: 142
Bid/Ask: 10.00 / 76.96
Day's Range: 76.93 - 77.68

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
Financials
Technical
Forum

Alnylam Pharmaceuticals DRC Company Profile

Explore the Alnylam Pharmaceuticals DRC company profile for core details about Alnylam Pharmaceuticals DRC, assess Alnylam Pharmaceuticals DRC company details, including a description of the company, key contact information, and insights into the top executives. Discover the company's operations and leadership to better understand its role in the industry.

IndustryPharmaceuticals

SectorHealthcare

Employees

2002

Equity Type

DRC

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer’s disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

Contact Information

Address 675 West Kendall Street Henri A. Termeer Square
Cambridge, 02142
United States

Phone 617 551 8200

Fax 617 551 8101

Web www.alnylam.com

Top Executives

Name	Age	Since	Title
Yvonne L. Greenstreet	60	2016	CEO & Director
David P. Bartel	-	-	Member of Scientific Advisory Board
Rachel Meyers	-	-	Member of Scientific Advisory Board
Olivier Brandicourt	67	2020	Independent Director
Dennis Arthur Ausiello	78	2012	Member of the Scientific Advisory Board & Independent Director
Daniel J. Rader	-	-	Member of Scientific Advisory Board
Margaret A. Hamburg	68	2019	Independent Director
Carolyn R. Bertozzi	57	2023	Independent Director
Markus Stoffel	-	-	Member of Scientific Advisory Board
Phillip A. Sharp	78	2002	Co-Founder, Member of the Scientific Advisory Board & Independent Director
Priya S. Kishnani	-	2020	Member of the Scientific Advisory Board
Charles Elliott Sigal	71	2022	Independent Director
David E. I. Pyott	71	2015	Independent Director
Colleen Foley Reitan	64	2018	Independent Director
Akshay K. Vaishnaw	61	2006	Chief Innovation Officer & Member of the Scientific Advisory Board
Peter N. Kellogg	68	2023	Independent Director
Amy W. Schulman	63	2014	Independent Chair of the Board & Lead Independent Director
Muthiah Manoharan	71	2003	Senior VP of Innovation Chemistry & Distinguished Scientist and Member of Scientific Advisory Board

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com India's comments guidelines and agree to the terms described.

I Agree

A1LN34 Comments

Write your thoughts about Alnylam Pharmaceuticals Inc DRC

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d56-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d56-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d56-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

Nifty 50	24,454.55	+178.50	+0.74%
BSE Sensex	80,908.16	+660.08	+0.82%
Nifty Bank	52,749.95	+640.95	+1.23%
Nifty 50 Futures	24,563.00	+134.50	+0.55%
US 500	6,050.4	+3.3	+0.05%
FTSE 100	8,358.85	+45.96	+0.55%
Dollar Index	106.144	-0.279	-0.26%

Gold	2,668.66	+10.16	+0.38%
Crude Oil WTI	68.74	+0.64	+0.94%
Brent Oil	72.48	+0.65	+0.90%
Natural Gas	3.191	-0.022	-0.68%
Silver	31.453	+0.589	+1.91%
Copper	831.50	-28.05	-3.26%
MCX Cotton	55,500	0.00	0.00%

SBI	853.55	+17.15	+2.05%
NTPC	367.55	+9.35	+2.61%
ICICI Bank	1,311.10	+6.45	+0.49%
Reliance Industries	1,321.65	+12.50	+0.95%
DLF	846.70	-2.40	-0.28%
Tata Motors	801.00	+10.95	+1.39%
Tata Steel Ltd	146.50	+0.09	+0.06%

USD/INR	84.638	-0.084	-0.10%
EUR/USD	1.0530	+0.0033	+0.31%
GBP/USD	1.2693	+0.0038	+0.30%
USD/JPY	149.85	+0.26	+0.17%
GBP/INR	107.443	+0.226	+0.21%
EUR/INR	89.1370	+0.1580	+0.18%
USD/CAD	1.4014	-0.0031	-0.22%

Recent Quotes

	Name	Price	Chg.	Chg. %
	A1LN34	77.28	+1.76	+2.33%

Market Movers

Name	Last	Chg. %	Vol.
Ola Electric Mobility	98.75	+5.85%	211.83M
HDFC Bank	1,830.25	+1.42%	17.76M
HDFC Bank	1,830.35	+1.42%	17.73M
Adani Ports & SEZ	1,290.70	+6.16%	15.39M
Reliance Industries	1,321.35	+0.93%	13.28M
Reliance Industries	1,321.00	+0.91%	13.27M
Mazagon Dock	4,691.20	+3.21%	3.00M

Name	Last	Chg. %	Vol.
Lincoln Pharmaceuticals Ltd	763.20	+20.00%	1.02M
Madhav Copper	63.84	+20.00%	2.16M
Lincoln Pharmaceuticals Ltd	754.10	+19.99%	70.28K
Bang Overseas Ltd	66.64	+19.99%	772.44K
Bang Overseas Ltd	66.94	+19.99%	94.43K
HOAC Foods India	137.20	+19.98%	42.75K
Transteel Seating Tech	54.10	+19.96%	1.79M

Name	Last	Chg. %	Vol.
Par Drugs	278.80	-19.99%	1.12M
Omni AX’s Software	3.41	-10.26%	2.35K
AKI India	16.11	-10.05%	826.20K
AKI India	16.20	-10.00%	106.30K
Vaxfab Enterprises	11.66	-9.96%	75.81K
Malu Paper Mills Ltd	48.30	-8.68%	40.99K
Malu Paper Mills Ltd	48.69	-8.06%	482.36K